Thursday, February 27, 2020

Monocyte Activation Test Market to Witness Huge Growth from 2019-2030 and Focusing on Top Key Players - Merck, Thermo Fisher Scientific, Becton

Monocyte activation test based on the reaction of human monocytes, now allows predicting the human response to all pyrogens (i.e. endotoxin and non-endotoxin) in vitro. The MAT can be used as alternative to animal-based pyrogen testing. The MAT is used to detect or quantify substances that activate human monocytes or monocyte cells to release endogenous mediators which have a role in the human fever response. The MAT offers significant advantages over animal-based pyrogen testing: based on the human fever response, it provides a more relevant prediction of pyrogenic activity than the rabbit pyrogen test (RPT), it can detect endotoxin and non-endotoxin pyrogens and is applicable to a greater variety of products than the RPT; moreover, it is more accurate as well as more cost and time-effective than various other pyrogen tests.

Market Industry Reports (MIR) has published a new report titled "Monocyte Activation Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." The global Monocyte Activation Test market was valued at over US$ 6.5 Mn. in 2018 and is anticipated to grow at a CAGR of 12.5% from 2019 to 2030.

Major Key Players of the Monocyte Activation Test Market are:
Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.

Read More @ http://www.sbwire.com/press-releases/monocyte-activation-test-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-merck-thermo-fisher-scientific-becton-1279336.htm 


The global monocyte activation test market is witnessing continuous advancements in test offerings and extensive growth in the product portfolio of major as well as local manufacturers. The growth of the global monocyte activation test market is attributed to increasing number of pharmaceutical and biotechnology industries globally, rising research and development, increased investments and surge in new drug approval activities. Additionally, a proposed ban on animal tests has resulted in reducing the use of the rabbit for pyrogen test. This is one of the significant factors that is driving the growth of monocyte activation tests globally. Increase in public and regulatory concerns about product safety further support the market growth.

Animals are used to test both the safety and efficacy of therapeutic drugs, cosmetics, household products, and chemicals. Fortunately there are developing numbers of effective non-animal alternatives that can replace the use of animals in pyrogen testing. Moreover, many countries have regulatory requirements that stipulate a ban on animal based pyrogen testing. There have been major changes in the European Union in recent years. In the EU the use of animals for pyrogen testing of cosmetic products has been banned since 2009, the use of animals for the testing of cosmetic ingredients also has been banned since March 2013.

Major Types of Monocyte Activation Test Market covered are:
Monocyte Activation Test Kits
Reagents

Major Applications of Monocyte Activation Test Market covered are:

Medical Devices
Lipid Parenteral
Dialysis Liquids
Blood Products
Toxic/immune-modulatory Drugs

Read More @ http://www.sbwire.com/press-releases/monocyte-activation-test-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-merck-thermo-fisher-scientific-becton-1279336.htm 

No comments:

Post a Comment